SNG Pharmaceuticals Private Limited
About SNG Pharmaceuticals Private Limited
Data last updated:
SNG Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 25 April 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC140164.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Gupta and Anil Surendranath Gupta.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 34/133 Laxmi Industrial Estatenew Link Road Andheri (West), Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.57 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹72.11 Lakh (net margin 74.7%) and EBITDA of ₹90.24 Lakh (EBITDA margin 93.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address34/133 Laxmi Industrial Estatenew Link Road Andheri (West), Mumbai, Maharashtra, India – 400053
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of SNG Pharmaceuticals Private Limited FY 2025 filings available
SNG Pharmaceuticals Private Limited reported revenue of ₹96.57 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of SNG Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 10% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of SNG Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹90.24 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹72.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of SNG Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 93.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 74.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of SNG Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Gupta Also directs: Adit Pharma Private Limited, Zen Pharma Private Limited, Gujarat Ampoules and Vials Pvt Ltd and 3 more | Director | 25 Apr 2003 | 23 Years 5 Months | Current |
| Renu Anil Gupta Also directs: Adit Pharma Private Limited, Gujarat Ampoules and Vials Pvt Ltd, Adit Containers Private Limited and 2 more | Additional Director | 13 Jun 2025 | 1 Years 4 Months | Current |
| Anil Surendranath Gupta Also directs: Adit Pharma Private Limited, Zen Pharma Private Limited, Gujarat Ampoules and Vials Pvt Ltd and 3 more | Director | 25 Apr 2003 | 23 Years 5 Months | Current |
Peer Comparison of SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hermadis Pharmaceuticals Private Limited | ₹97.59 Lakh (FY 2023) | •••• | •••• | -79.0% | •••• | Chennai, Tamil Nadu, India |
| Biocordis Pharmaceuticals Private Limited | ₹97.53 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Chandigarh, India |
| Brainstem Pharmaceuticals (OPC) Private Limited | ₹97.06 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Medchal, Telangana, India |
| Nuthelia Pharmaceuticals Private Limited | ₹96.95 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Doqtec Pharmaceuticals Private Limited | ₹96.83 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Bhiwani, Haryana, India |
| SNG Pharmaceuticals Private Limited this company | ₹96.57 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| RML Pharmaceuticals Private Limited | ₹96.47 Lakh (FY 2016) | •••• | •••• | 1186.0% | •••• | New Delhi, Delhi, India |
| Medrica Pharmaceuticals Private Limited | ₹96.26 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Keven Pharmaceuticals Private Limited | ₹96.21 Lakh (FY 2023) | •••• | •••• | 465.0% | •••• | Balapur, Telangana, India |
| Zealous Pharmaceuticals Private Limited | ₹95.71 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Bhopal, Madhya Pradesh, India |
| Dr. Bird Pharmaceuticals (OPC) Private Limited | ₹95.56 Lakh (FY 2024) | •••• | •••• | 146.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below SNG Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals Private Limited is audited by S. V. DOSHI & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. V. DOSHI & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of SNG Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at SNG Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to SNG Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals Private Limited has 3 board changes on record since 2003: 3 appointments. The latest: Renu Anil Gupta was appointed as Additional Director on 13 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts for SNG Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by SNG Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of SNG Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of SNG Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of SNG Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 25 April 2003 (23+ years old) and is registered under CIN U24230MH2003PTC140164.
SNG Pharmaceuticals reported revenue of ₹96.57 Lakh for FY 2025 (up 10% YoY).
SNG Pharmaceuticals has 3 current directors:
- Amit Gupta - Director
- Renu Anil Gupta - Additional Director
- Anil Surendranath Gupta - Director
SNG Pharmaceuticals reported a net profit of ₹72.11 Lakh (net margin 74.7%) and EBITDA of ₹90.24 Lakh (EBITDA margin 93.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of SNG Pharmaceuticals is 26% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of SNG Pharmaceuticals is U24230MH2003PTC140164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SNG Pharmaceuticals was incorporated on 25 April 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of SNG Pharmaceuticals by revenue are Hermadis Pharmaceuticals Private Limited, Biocordis Pharmaceuticals Private Limited, Brainstem Pharmaceuticals (OPC) Private Limited, Nuthelia Pharmaceuticals Private Limited, Doqtec Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Renu Anil Gupta was appointed as Additional Director on 13 Jun 2025. Amit Gupta was appointed as Director on 25 Apr 2003. Anil Surendranath Gupta was appointed as Director on 25 Apr 2003.
The registered office of SNG Pharmaceuticals is at 34133 Laxmi Industrial Estatenew Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
SNG Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.